Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NUFIP1 pseudogene 1 is a non-protein-coding genomic element identified as a pseudogene related to the Nuclear FMR1 interacting protein 1 gene. Unlike its protein-coding counterpart, it does not produce a functional RNA-binding protein and is not known to have any independent biological or disease-associated role. Pseudogenes typically arise from duplication or retrotransposition events and do not code for active proteins. While the functional NUFIP1 gene participates in ribosome biology, RNA binding, and may influence cancer and neurodevelopmental disease, NUFIP1 pseudogene 1 itself has no evidence of being a therapeutic target, mechanism of drug action, or clinically relevant biomarker[9][1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NUFIP1 pseudogene 1 (NUFIP1P1).